Narcostop 5 mg/ml, solution for injection for cats and dogs
Narcostop 5 mg/ml, solution for injection for cats and dogs
Authorised
- Atipamezole hydrochloride
Product identification
Medicine name:
Narcostop 5 mg/ml, solution for injection for cats and dogs
Narcostop 5 mg/ml Oplossing voor injectie
Narcostop 5 mg/ml Solution injectable
Narcostop 5 mg/ml Injektionslösung
Active substance:
- Atipamezole hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Atipamezole hydrochloride5.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QV03AB90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Cardboard box with 5 vials containing 10 ml. Clear glass (type I) vial with bromobutylrubber stopper (type I) containing 10 ml solution for injection.
- Cardboard box with 10 vials containing 10 ml. Clear glass (type I) vial with bromobutylrubber stopper (type I) containing 10 ml solution for injection.
- Cardboard box with 1 vial containing 10 ml. Clear glass (type I) vial with bromobutylrubber stopper (type I) containing 10 ml solution for injection.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Produlab Pharma B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V370264
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0139/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Finland
-
France
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Luxembourg
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 13/06/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.